Mast Cell Activation, Neuroinflammation, and Tight Junction Protein Derangement in Acute Traumatic Brain Injury

Area of Science:

• Neuroscience
• Immunology
• Pathophysiology

Background:

• Traumatic brain injury (TBI) is a leading cause of death and disability worldwide.
• TBI induces primary and secondary brain damage, including neuroinflammation and neurodegeneration.
• The role of mast cells and associated neuroinflammatory pathways in TBI pathophysiology requires further investigation.

Purpose of the Study:

• To investigate the role of mast cell activation and neuroinflammation in a mouse model of TBI.
• To analyze the expression of key inflammatory markers and blood-brain barrier proteins following TBI.

Main Methods:

• Weight drop-induced TBI model in mice.
• Toluidine blue staining for mast cell activation.
• Enzyme-linked immunosorbent assay (ELISA) for serum CCL2 levels.
• Western blot analysis for PAR-2, VEGFR2, claudin 5, and ZO-1 protein expression.

Main Results:

• Increased mast cell activation and numbers were observed in TBI brains at 24 and 72 hours post-injury.
• Elevated levels of CCL2, PAR-2, and VEGFR2 were detected in TBI mouse brains.
• TBI led to the disruption of tight junction proteins claudin 5 and ZO-1, indicating increased blood-brain barrier permeability.

Conclusions:

• TBI triggers mast cell activation and neuroinflammation, contributing to blood-brain barrier disruption.
• Targeting mast cell activation presents a potential therapeutic avenue to mitigate TBI-induced neuroinflammation and neurodegeneration.